Author

V. Impedovo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

J. Busquets· 1 shared M.-J. Lu· 1 shared S. Tiziani· 1 shared W. Matsui· 1 shared X. A. Cambronne· 1 shared Y.-T. Chang· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

J. Busquets

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintNov 15, 2022

SLC25A51 impacts drug sensitivity in AML cells by sustaining mitochondrial oxidative flux

M.-J. Lu, J. Busquets, V. Impedovo…·X. A. Cambronne

This study shows that SLC25A51 sustains mitochondrial oxidative flux in AML, leading to drug sensitivity when inhibited, especially with glutaminase inhibitors.

DOI 10.1101/2022.11.15.516643

humanbulk RNA-seq

𝕏 PostBluesky